Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model.

PLoS pathogens·2026

Same author

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.

Blood neoplasia·2026

Same author

A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Blood·2026

Same author

The Biology and Clinical Utility of EBV Monitoring in Blood.

Current topics in microbiology and immunology·2026

Same author

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

Nature cancer·2025

Same author

EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND T<sub>REG</sub>-DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

Epstein-Barr virus-associated lymphoproliferative disorders.

Richard F Ambinder¹

¹Hematologic Malignancies Division, Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins School of Medicine, Bunting-Blaustein Cancer Research Building, Rm 389, 1650 Orleans St, Baltimore, MD 21231, USA. ambinri@jbmi.edu

Reviews in Clinical and Experimental Hematology

|May 8, 2004

Summary

Epstein-Barr virus (EBV) drives proliferation and cell death resistance in lymphomas. Understanding EBV

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Related Experiment Videos

Last Updated: Jun 28, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Area of Science:

Virology
Oncology
Immunology

Background:

Epstein-Barr virus (EBV), a herpesvirus, is linked to various lymphomas and lymphoproliferative diseases.
EBV encodes genes that promote cell proliferation and inhibit cell death.
Viral proteins can mimic cellular signaling proteins, influencing disease development.

Purpose of the Study:

To explore the association between Epstein-Barr virus and different types of lymphomas.
To understand the varying roles of EBV genes in different tumor types.
To highlight the diagnostic and therapeutic implications of EBV in lymphoproliferative diseases.

Main Methods:

Review of scientific literature on EBV and associated malignancies.
Analysis of EBV gene expression patterns in different lymphomas.
Examination of EBV's role in immune surveillance evasion.

Main Results:

EBV association with lymphomas varies globally and by specific cancer type (e.g., nasal NK/T-cell lymphoma vs. Burkitt's lymphoma).
Different EBV genes are critical in distinct tumors, affecting immune evasion.
Some EBV-driven tumors are sensitive to T-cell surveillance, while others are resistant.

Conclusions:

EBV's role in lymphomagenesis is complex and context-dependent.
Understanding EBV's specific interactions is crucial for accurate diagnosis and targeted therapies.
EBV association impacts disease pathogenesis, immune evasion, and treatment strategies.